Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2107)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (105)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (846)
  3. JNCI: Journal of the National Cancer Institute (485)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Medulloblastoma utilize GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination
    Meeting Abstract

    Martirosian, V.; Deshpande, K.; Zhou, H.; Shen, K.; Stepanosyan, V.; Remsik, J.; Boire, A.; Isakov, D.; De Feyter, H.; Hurth, K.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Salvage resection of recurrent previously-irradiated brain metastases: Clinical and radiographic outcomes
    Meeting Abstract

    Wilcox, J.; Newman, W.; Reiner, A.; Brown, S.; Young, R.; Chen, J.; Beal, K.; Brennan, C.; Panageas, K.; Tabar, V.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Adjuvant SBRT for resected brain metastases: The effect of timing on long-term intended-field control
    Meeting Abstract

    Bander, E.; Yuan, M.; Reiner, A.; Panageas, K.; Brennan, C.; Beal, K.; Tabar, V.; Moss, N.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • INDIGO: A global, randomized, double-blind, phase 3 study of vorasidenib (AG-881) vs placebo in patients with residual/recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation
    Meeting Abstract

    Mellinghoff, I.; van den Bent, M.; Clarke, J.; Maher, E.; Peters, K.; Touat, M.; de Groot, J.; De La Fuente, M.; Arrillaga-Romany, I.; Wick, W.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Buxton, M.; Alexander, B.; Berry, D.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B.; Gordon, G.; Khasraw, M.; Lassman, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Not all GBM stem cells are equal: Implications for research and therapy
    Meeting Abstract

    Galdieri, L.; Jash, A.; Malkova, O.; Mao, D.; Campian, J.; Brennan, C.; Oh, S.; Kim, A.; Chheda, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Risk of tract recurrence with stereotactic biopsy of brain metastases: An 18-year cancer center experience
    Meeting Abstract

    Carnevale, J.; Winston, G.; Goldberg, J.; Brennan, C.; Tabar, V.; Moss, N.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Malignant melanoma in neurocutaneous melanocytosis: A retrospective case series (2000-2020)
    Meeting Abstract

    Elmore, K.; Sener, U.; Ennin, E.; Suser, S.; Marghoob, A.; Haque, S.; Khakoo, Y.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of survival following treatment with bevacizumab in glioblastoma patients with radiographically-confirmed subependymal or leptomeningeal spread of disease
    Meeting Abstract

    Farooq, S.; Yildirim, O.; Young, R.; Tisnado, J.; Miller, A.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence and reduced survival in initially low grade IDH-mutant gliomas
    Meeting Abstract

    Yu, Y.; Villanueva-Meyer, J.; Chang, S.; Grimmer, M.; Hilz, S.; Solomon, D.; Choi, S.; Wahl, M.; Mazor, T.; Hong, C. B.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save